NO! It is a thankless dead end job! They are manager heavy and most managers do not have a clue as to what is really going on as they are all holding each others...
It is true, but a few things need to happen first. JNJ will buy BSX and then James Tobin who is now at Aptus Endosystems will be buy it all, and live happily ever after! Right after you become the RNC's selection to run against a resurrected JFK as president! Then, the sale goes through.
upheld a lower court ruling that four patents on drug-coated stents owned by J&J’s Cordis unit are invalid because the company failed to accurately describe the invention.
This would make the BSX patents valid! time to crush JNJ!
I see the trading in the $10 to $13 but your a moron for thinking MDT would even think about a purchase! They are dropping work force by 2000 people, and they are having financial difficulties of there own! do you even think for a minute the FTC would allow a merge between the two? what a meat head! Pick someone else, like Tyco or Lowe's or oh I know, maybe Merck... no no Jack in the box, they put an offer in last night, yeah that's it!
U.S. District Judge Sue Robinson told jurors in Wilmington today that another jury in 2005 ruled Cordis infringed the patent.
“They ran out of appeals,”
Boston Scientific is seeking $34 million, or more than half of the Johnson & Johnson (JNJ) unit’s $60 million in sales of the stent.
This is nothing new! They have always been pro-active in cases like this and others. Yet, for doing the right thing, they get beat on! Well bring it on!
Hey peachesd and cream!
BSX owns the Xience V platform...
hello and welcome to years ago!
Keep trying though, I still think you three are funny, it gives me a laugh in the am...